At a glance
ClinicalIndex Comparison RecordPhase 3Completed· 100 enrolled
Drug / intervention
Glucosamine sulphate and chondroitin sulphate association +1 moredrug
Likely dose
Glucosamine sulphate and chondroitin sulphate association 500 mgfrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
A Multi-center, Randomized, Double Blind, Comparative of Efficacy and Safety From Association of Capsules Glucosamine and Chondroitin Sulfate (Eurofarma) Versus Cosamin DS to Treatment With Osteoarthrosis of the Knee
In Brief
A Phase 3 clinical trial evaluating Glucosamine sulphate and chondroitin sulphate association and Cosamin DS® (Nutramax) for Osteoarthritis of the Knee. Completed, enrolled 100 participants across 4 sites.
Detailed Summary
The purpose of this study is to assess the efficacy and safety of glucosamine and chondroitin sulfate association in the treatment of patients with osteoarthrosis of the knee.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsOsteoarthritis of the Knee
CountriesBrazil
Collaborators--
Timeline
Phase 3CompletedFinished
20102011201220132014201520162017201820192020202120222023202420252026
First PostedAug 2009
Enrollment StartAug 2010
Primary CompletionFeb 2011
Study CompletionJun 2011
TodayJul 2026
First PostedAug 10, 2009
Enrollment StartAug 1, 2010
Primary CompletionFeb 1, 2011
Study CompletionJun 1, 2011
TodayJul 2, 2026
Enrollment to primary: 6 monthsPosted 16.9 years ago
Interventions
Glucosamine sulphate and chondroitin sulphate associationdrug
glucosamine sulphate 500 mg and chondroitin sulphate 400 mg association T.I.D. before each meal
Cosamin DS® (Nutramax)drug
oral capsule of glucosamine hydrochloride 500 mg + chondroitin sulphate 400 mg thrice daily before meals. Period: 127 days